Rxivist logo

Copy number signatures predict chromothripsis and associate with poor clinical outcomes in patients with newly diagnosed multiple myeloma

By Kylee Maclachlan, Even H Rustad, Andriy Derkach, Binbin Zheng-Lin, Venkata Yellapantula, Benjamin Diamond, Malin Hultcrantz, Bachisio Ziccheddu, Eileen Boyle, Patrick Blaney, Niccolo Bolli, Yanming Zhang, Ahmet Dogan, Alexander Lesohkin, Gareth Morgan, Ola Landgren, Francesco Maura

Posted 24 Nov 2020
bioRxiv DOI: 10.1101/2020.11.24.395939

Chromothripsis is detectable in 20-30% of newly diagnosed multiple myeloma (NDMM) patients and is emerging as a new independent adverse prognostic factor. In this study, we interrogate 752 NDMM patients using whole genome sequencing (WGS) to study the relationship of copy number (CN) signatures to chromothripsis and show they are highly associated. CN signatures are highly predictive of the presence of chromothripsis (AUC=0.90) and can be used to identify its adverse prognostic impact. The ability of CN signatures to predict the presence of chromothripsis was confirmed in a validation series of WGS comprised of 235 hematological cancers (AUC=0.97) and an independent series of 34 NDMM (AUC=0.87). We show that CN signatures can also be derived from whole exome data (WES) and using 677 cases from the same series of NDMM, we were able to predict both the presence of chromothripsis (AUC=0.82) and its adverse prognostic impact. CN signatures constitute a flexible tool to identify the presence of chromothripsis and is applicable to WES and WGS data.

Download data

  • Downloaded 221 times
  • Download rankings, all-time:
    • Site-wide: 110,830
    • In genomics: 6,370
  • Year to date:
    • Site-wide: 56,804
  • Since beginning of last month:
    • Site-wide: 47,917

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide